Activation of the GPR35 signaling pathway promotes tumor angiogenesis in the TME, and loss of GPR35 in macrophages reduces matrix metalloproteinase activity in tumor tissues, a prerequisite for tissue remodeling and angiogenesis. This evidence concerns the gene GPR35 and neoplasm.